# Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)

> **NCT01441960** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 45 (actual)

## Conditions studied

- Neuromuscular Blockade
- ECT

## Interventions

- **DRUG:** Succinylcholine
- **DRUG:** Rocuronium

## Key facts

- **NCT ID:** NCT01441960
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-07
- **Final completion:** 2015-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2015-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441960, "Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01441960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*